US

Paul Neilsen

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Neilsen. Retrieved from https://idiyas.com/inventor/paul-neilsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Paul Neilsen - Innovator in Lipid Assay Technology.

Introduction

Paul Neilsen is a notable inventor based in the United States, recognized for his contributions to the field of lipid assay technology. His innovative work focuses on methods and apparatuses that enhance the detection of lipids and associated enzymes, which are crucial in various biological and medical applications.

Latest Patents

Neilsen's most significant patent is titled "Assaying Apparatus, Kit, And Method For Lipids And Associated Enzymes." This invention involves a lipid assay method, kit, and apparatus that utilize a protein with a lipid recognition motif. The method allows for the interaction between a target lipid and a competing lipid, enabling the determination of the presence of the target lipid in a solution. The assay is particularly valuable as it can serve as a cancer screening method, where the detection of specific levels of a phosphoinositide target lipid indicates the presence of cancer cells.

Career Highlights

Paul Neilsen is currently associated with Echelon Biosciences Incorporated, where he continues to develop innovative solutions in lipid research. His work has the potential to significantly impact cancer diagnostics and other areas of biomedical research.

Collaborations

Neilsen collaborates with esteemed colleagues, including Michael J. Mostert and Glenn D. Prestwich, who contribute to the advancement of lipid assay technologies.

Conclusion

Paul Neilsen's innovative work in lipid assay technology exemplifies the importance of research and development in the medical field. His contributions are paving the way for improved diagnostic methods and enhancing our understanding of lipid-related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…